Clinical trial
Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60: DA Versus…
NCT00180167 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00180167 |
|---|---|
| Title | Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC |
| Official title | Therapy of AML in Patients Older Than 60 Years: Randomized Comparison of a Double Induction With Daunorubicin and AraC (as Continuous Infusion) With a Double Induction With Mitoxantrone and Intermittent, Medium High Dose AraC |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Leukemia, Nonlymphocytic, Acute |
| Intervention type | Drug |
| Interventions | randomization between two established Chemotherapies |
| Enrollment | 492 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 20, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: